Showing 9 of 9 recruiting trials for “alveolar-rhabdomyosarcoma”
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
👨⚕️ Chandrika Behura, MD, Penn State Health Children's Hospital📍 20 sites📅 Started Oct 2024View details ↗
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
👨⚕️ Lars Wagner, M.D., Duke University Children's Hospital & Health Center📍 8 sites📅 Started Oct 2021View details ↗
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
👨⚕️ Svetlana Kulyova, MD, Phd, Head of Children's Oncology Department📍 1 site📅 Started May 2021View details ↗
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
👨⚕️ Edmund Bartlett, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Apr 2020View details ↗
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →